MedPath

Comparative Study of the NIDEK TONOREF III with Predicate Devices

Not Applicable
Completed
Conditions
Intraocular Pressure
Interventions
Device: NIDEK TONOREF III
Device: Haag-Streit, PERKINS HAND-HELD APPLANATION TONOMETER
Device: NIDEK CEM-530
Registration Number
NCT06363045
Lead Sponsor
Nidek Co. LTD.
Brief Summary

The primary objective of this clinical study is to prove that tonometry values for NIDEK TONOREF III are comparable to the predicate device and to prove that the pachymeter function of NIDEK TONOREF III is equivalent to the predicate device. The secondary objective is to demonstrate that the test device is as safe as the predicate devices.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
183
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Adults 18 years old or olderNIDEK TONOREF IIINIDEK TONOREFIII
Adults 18 years old or olderHaag-Streit, PERKINS HAND-HELD APPLANATION TONOMETERNIDEK TONOREFIII
Adults 18 years old or olderNIDEK CEM-530NIDEK TONOREFIII
Primary Outcome Measures
NameTimeMethod
Equivalent to legally-marketed devicesOne or two study visits per subject. One visit is less than two hours.

Agreement of intraocular pressure (mmHg) measurement for TONOREFIII and PAT

Equivalent to the pachymeter functionOne or two study visits per subject. One visit is less than two hours.

Agreement of central corneal thickness (µm) measurement for TONOREF III and CEM-530

Secondary Outcome Measures
NameTimeMethod
The numbers of adverse eventsOne or two study visits per subject. One visit is less than two hours.

To demonstrate that the test device is as safe as the predicate devices.

Trial Locations

Locations (1)

Aston University

🇬🇧

Birmingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath